Extracellular vesicles-based biomarkers represent a promising liquid biopsy in endometrial cancer
© 2019 by the authors.
| Autores: | , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2019 |
| País: | España |
| Institución: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/206674 |
| Acceso en línea: | http://hdl.handle.net/10261/206674 |
| Access Level: | acceso abierto |
| Palabra clave: | EVs ExoGAG Endometrial cancer ANXA2 |
| id |
ES_7fc5b93bfc5af148ee95feaa2253a407 |
|---|---|
| oai_identifier_str |
oai:digital.csic.es:10261/206674 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Extracellular vesicles-based biomarkers represent a promising liquid biopsy in endometrial cancerHerrero, CarolinaFuente, Alexandre de laCasas-Arozamena, CarlosSebastián, VíctorPrieto, MartínArruebo, ManuelAbalo, AliciaColas, EvaMoreno-Bueno, GemaGil-Moreno, AntonioVilar, AnaCueva, JuanAbal, MiguelMuinelo-Romay, LauraEVsExoGAGEndometrial cancerANXA2© 2019 by the authors.Tumor-derived extracellular vesicles (EVs) are secreted in large amounts into biological fluids of cancer patients. The analysis of EVs cargoes has been associated with patient´s outcome and response to therapy. However, current technologies for EVs isolation are tedious and low cost-efficient for routine clinical implementation. To explore the clinical value of circulating EVs analysis we attempted a proof-of-concept in endometrial cancer (EC) with ExoGAG, an easy to use and highly efficient new technology to enrich EVs. Technical performance was first evaluated using EVs secreted by Hec1A cells. Then, the clinical value of this strategy was questioned by analyzing the levels of two well-known tissue biomarkers in EC, L1 cell adhesion molecule (L1CAM) and Annexin A2 (ANXA2), in EVs purified from plasma in a cohort of 41 EC patients and 20 healthy controls. The results demonstrated the specific content of ANXA2 in the purified EVs fraction, with an accurate sensitivity and specificity for EC diagnosis. Importantly, high ANXA2 levels in circulating EVs were associated with high risk of recurrence and non-endometrioid histology suggesting a potential value as a prognostic biomarker in EC. These results also confirmed ExoGAG technology as a robust technique for the clinical implementation of circulating EVs analyses.This research was funded by Instituto de Salud Carlos III, grant PI17/01919, co-financed by the European Regional Development Fund (FEDER), and by Fundación Científica de la Asociación Española Contra el Cáncer (AECC), Grupos Clínicos Coordinados 2018. Carolina Herrero is supported by a predoctoral i-PFIS fellowship from Instituto de Salud Carlos III (IFI17/00047); Laura Muinelo is supported by Asociación Española Contra el Cáncer (AECC).Multidisciplinary Digital Publishing InstituteInstituto de Salud Carlos IIIEuropean CommissionAsociación Española Contra el CáncerConsejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]2020202020192020info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501Publisher's versioninfo:eu-repo/semantics/publishedVersionhttp://hdl.handle.net/10261/206674reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Ingléshttp://dx.doi.org/10.3390/cancers11122000Síinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/2066742026-05-22T06:33:51Z |
| dc.title.none.fl_str_mv |
Extracellular vesicles-based biomarkers represent a promising liquid biopsy in endometrial cancer |
| title |
Extracellular vesicles-based biomarkers represent a promising liquid biopsy in endometrial cancer |
| spellingShingle |
Extracellular vesicles-based biomarkers represent a promising liquid biopsy in endometrial cancer Herrero, Carolina EVs ExoGAG Endometrial cancer ANXA2 |
| title_short |
Extracellular vesicles-based biomarkers represent a promising liquid biopsy in endometrial cancer |
| title_full |
Extracellular vesicles-based biomarkers represent a promising liquid biopsy in endometrial cancer |
| title_fullStr |
Extracellular vesicles-based biomarkers represent a promising liquid biopsy in endometrial cancer |
| title_full_unstemmed |
Extracellular vesicles-based biomarkers represent a promising liquid biopsy in endometrial cancer |
| title_sort |
Extracellular vesicles-based biomarkers represent a promising liquid biopsy in endometrial cancer |
| dc.creator.none.fl_str_mv |
Herrero, Carolina Fuente, Alexandre de la Casas-Arozamena, Carlos Sebastián, Víctor Prieto, Martín Arruebo, Manuel Abalo, Alicia Colas, Eva Moreno-Bueno, Gema Gil-Moreno, Antonio Vilar, Ana Cueva, Juan Abal, Miguel Muinelo-Romay, Laura |
| author |
Herrero, Carolina |
| author_facet |
Herrero, Carolina Fuente, Alexandre de la Casas-Arozamena, Carlos Sebastián, Víctor Prieto, Martín Arruebo, Manuel Abalo, Alicia Colas, Eva Moreno-Bueno, Gema Gil-Moreno, Antonio Vilar, Ana Cueva, Juan Abal, Miguel Muinelo-Romay, Laura |
| author_role |
author |
| author2 |
Fuente, Alexandre de la Casas-Arozamena, Carlos Sebastián, Víctor Prieto, Martín Arruebo, Manuel Abalo, Alicia Colas, Eva Moreno-Bueno, Gema Gil-Moreno, Antonio Vilar, Ana Cueva, Juan Abal, Miguel Muinelo-Romay, Laura |
| author2_role |
author author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Instituto de Salud Carlos III European Commission Asociación Española Contra el Cáncer Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72] |
| dc.subject.none.fl_str_mv |
EVs ExoGAG Endometrial cancer ANXA2 |
| topic |
EVs ExoGAG Endometrial cancer ANXA2 |
| description |
© 2019 by the authors. |
| publishDate |
2019 |
| dc.date.none.fl_str_mv |
2019 2020 2020 2020 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 Publisher's version info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10261/206674 |
| url |
http://hdl.handle.net/10261/206674 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
http://dx.doi.org/10.3390/cancers11122000 Sí |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute |
| publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute |
| dc.source.none.fl_str_mv |
reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC instname:Consejo Superior de Investigaciones Científicas (CSIC) |
| instname_str |
Consejo Superior de Investigaciones Científicas (CSIC) |
| reponame_str |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| collection |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869411849307422720 |
| score |
15,812429 |